The prime objective of any pharmaceutical plant is to manufacture products of requisite quality at the lowest possible cost. Good manufacturing practices for pharmaceutical products require that critical processes, which may affect product quality, have to be validated. The rationale behind this is that if more effort is placed on development and validation at the beginning, then there will be no chance for failure during product life. The main objectives of process validation are to prove that the process is consistently undergoing what it is supposed to undergo which means that the process is under control and to determine the process variables and acceptable limits for these variables and to set up appropriate in-process controls. The application of a process validation program simply proves that the process step being evaluated reliably does what was expected of it. A successful process validation effort thus builds quality into the process so that the reliance on end product testing can be minimized. In the present study, concurrent process validation studies were carried out for Ramipril as per the Batch production record. The tablets were evaluated for various physiochemical parameters by official procedures. The
Validation, Concurrent process validation, Good manufacturing practices, Ramipril tablets
